Related Experiment Video
Updated: Dec 11, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Deubiquitination of CD36 by UCHL1 promotes foam cell formation
Xiaohong Xia1,2, Qiong Xu1, Mingke Liu1
1Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, 510260, Guangzhou, China.
Insights
UCHL1 deletion inhibits foam cell formation in atherosclerosis by promoting CD36 protein degradation. This finding suggests UCHL1 as a potential therapeutic target for treating atherosclerosis and related cardiovascular diseases.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Medicine
Background:
- Atherosclerosis, a leading cause of global mortality, involves macrophage foam cell formation.
- Scavenger receptors are crucial for foam cell development, driven by modified lipoprotein uptake.
- Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is implicated in various cancers, but its role in atherosclerosis is unclear.
Purpose of the Study:
- To investigate the role of UCHL1 in macrophage foam cell formation and lipid accumulation.
- To determine the molecular mechanisms by which UCHL1 influences cellular uptake of modified lipoproteins.
Main Methods:
- Utilized UCHL1 deletion models and pharmacological inhibitors/siRNA to modulate UCHL1 activity.
- Assessed lipid accumulation and foam cell formation in macrophages.
- Quantified the expression of scavenger receptors (CD36, SR-A, ABCA1, ABCG1, Lox-1, SR-B1) and CD36 ubiquitination.
- Investigated the effect of CD36 blockade on lipid uptake.
Main Results:
- UCHL1 deletion significantly inhibited lipid accumulation and foam cell formation.
- UCHL1 inhibition downregulated CD36 expression, without affecting other scavenger receptors.
- UCHL1 inhibition increased K48-polyubiquitination of CD36, suggesting enhanced degradation.
- Blocking CD36 activation attenuated the suppression of lipid uptake caused by UCHL1 deficiency.
Conclusions:
- UCHL1 deletion reduces foam cell formation by enhancing CD36 protein degradation.
- UCHL1 plays a critical role in regulating CD36-mediated lipid uptake.
- UCHL1 inhibition presents a potential therapeutic strategy for atherosclerosis treatment.
Abstract:
Atherosclerosis-associated cardiovascular diseases are main causes leading to high mortality worldwide. Macrophage-derived foam cell formation via uptaking modified lipoproteins is the initial and core step in the process of atherosclerosis. Meanwhile, scavenger receptor is indispensable for the formation of foam cells. UCHL1, a deubiquitinase, has been widely studied in multiple cancers. UCHL1 could be an oncogene or a tumor suppressor in dependent of tumor types. It remains unknown whether UCHL1 influences cellular oxLDL uptake. Herein we show that UCHL1 deletion significantly inhibits lipid accumulation and foam cell formation. Subsequently, we found that UCHL1 inhibitor or siRNA downregulates the expression of CD36 protein whereas SR-A, ABCA1, ABCG1, Lox-1, and SR-B1 have no significant change. Furthermore, the treatment of UCHL1 inhibition increases the abundance of K48-polyubiquitin on CD36 and the suppression of lipid uptake induced by UCHL1 deficiency is attenuated by blocking CD36 activation. Our study concluded that UCHL1 deletion decreases foam cell formation by promoting the degradation of CD36 protein, indicating UCHL1 may be a potential target for atherosclerosis treatment.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor-mediated Endocytosis
Inflammation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Export of Misfolded Proteins out of the ER

